Delivery Order SPE2DB20D2104-SPE2DB25FMUMA
Award Date
7/1/25
Potential Completion Date
7/2/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,405.49, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a medication used to treat diabetes. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,505.45, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3ml, a diabetes medication. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a diabetes medication, with a ceiling value of $8,945.99 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order, indicating the order is for a specific quantity of a product at a predetermined price....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,739.88, is for the delivery of a quantity of 3-pack, 18 mg/3 ml liraglutide medication. The contract has a firm fixed price pricing type and an ultimate completion date of February 10, 2025. The contract is not designated with a set-aside requirement. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,629.46, is for the delivery of Liraglutide 3-pak 18 mg/3 ml 3 ml, a diabetes medication. The contract has a firm fixed price and an ultimate completion date of July 18, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of pharmaceutical products, including a 3-pack of the diabetes treatment Liraglutide 18 mg/3 mL. The delivery order has a ceiling value of $8,359.20 and a period of performance through May 12, 2025. The contract is a firm fixed-price delivery order and does not utilize any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,890.62, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a diabetes medication. The contract is a firm fixed-price delivery order with a completion date of May 1, 2025. AmerisourceBergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania, is the prime contractor. This...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The $15,576.78 contract is for the supply of a diabetes medication, Liraglutide 3-Pak 18 mg/3 mL 3mL. The order has a completion date of May 7, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which enables the...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,142,269 units of the diabetes medication Liraglutide 2-Pak 18 mg/3 ml 3 ml. The contract is a firm fixed-price delivery order with a ceiling value of $1,320.00 and a performance period extending through May 6, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,007.13, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a medication used for the treatment of diabetes. The contract is a firm fixed-price delivery order with a completion date of March 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...